BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raggi F, Bosco MC. Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1). Cancers (Basel) 2020;12:E1337. [PMID: 32456204 DOI: 10.3390/cancers12051337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Muller M, Haghnejad V, Lopez A, Tiotiu A, Renaud S, Derive M, Bronowicki J. Triggering Receptors Expressed on Myeloid Cells 1 : Our New Partner in Human Oncology? Front Oncol 2022;12:927440. [DOI: 10.3389/fonc.2022.927440] [Reference Citation Analysis]
2 Xie Z, Li X, He Y, Wu S, Wang S, Sun J, He Y, Lun Y, Xin S, Zhang J. Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer via Bioinformatics Methods. Front Endocrinol (Lausanne) 2021;12:646793. [PMID: 34122331 DOI: 10.3389/fendo.2021.646793] [Reference Citation Analysis]
3 Wang L, Gao Y, Zhang G, Li D, Wang Z, Zhang J, Hermida LC, He L, Wang Z, Si J, Geng S, Ai R, Ning F, Cheng C, Deng H, Dimitrov DS, Sun Y, Huang Y, Wang D, Hu X, Wei Z, Wang W, Liao X. Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade. Sci Transl Med 2020;12:eaax2282. [DOI: 10.1126/scitranslmed.aax2282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]